Journal article
The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.
Abstract
OBJECTIVE: To compare the effects of a 12-week treatment course of a rosiglitazone-based versus a metformin- or glyburide-based strategy on inflammatory biomarkers and adipokine levels in hypertensive, type 2 diabetes patients.
METHODS: One hundred three treatment-naive patients or patients on monotherapy with either metformin or glyburide, and a hemoglobin A1C (A1C) ≥7.5%, were randomly assigned to either rosiglitazone add-on (4 mg/day ± …
Authors
Gupta M; Teoh H; Kajil M; Tsigoulis M; Quan A; Braga MF; Verma S
Journal
The Cardiology, Vol. 17, No. 4, pp. 191–196
Publication Date
2012
ISSN
1811-8194